Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $168,153 - $213,749
3,054 Added 8.21%
40,239 $2.26 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $2.13 Million - $2.59 Million
37,185 New
37,185 $2.24 Million
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $931,523 - $1.51 Million
20,128 New
20,128 $1.39 Million
Q4 2022

Feb 14, 2023

BUY
$38.8 - $55.46 $619,752 - $885,862
15,973 New
15,973 $797,000
Q1 2022

May 16, 2022

SELL
$31.02 - $48.18 $248,532 - $386,018
-8,012 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $329,613 - $456,523
8,012 New
8,012 $373,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.